Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 6/20 | 0.51 |
| ▸ | LIPC | P11150 | 1/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
| ▸ | OGA | O60502 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 5/20 | 0.33 |
| ▸ | CA1 | P00915 | 5/20 | 0.33 |
| ▸ | CA2 | P00918 | 5/20 | 0.33 |
| ▸ | CA4 | P22748 | 5/20 | 0.33 |
| ▸ | CA7 | P43166 | 5/20 | 0.33 |
| ▸ | CA9 | Q16790 | 5/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1728193 | 1.00 | SCD (0.51) | SCDLIPCLIPGOGACA12 | |
| SCHEMBL1726740 | 1.00 | SCD (0.51) | SCDLIPCLIPGOGACA12 | |
| SCHEMBL1728191 | 1.00 | SCD (0.51) | SCDLIPCLIPGOGACA12 | |
| SCHEMBL1726742 | 1.00 | SCD (0.51) | SCDLIPCLIPGOGACA12 | |
| SCHEMBL384773 | 0.88 | SCD (0.51) | SCDLIPGHCRTR1HCRTR2 | |
| SCHEMBL384772 | 0.88 | SCD (0.51) | SCDLIPGHCRTR1HCRTR2 | |
| SCHEMBL384774 | 0.88 | SCD (0.51) | SCDLIPGHCRTR1HCRTR2 | |
| SCHEMBL431369 | 0.83 | SCD (0.48) | SCDHCRTR1HCRTR2 | |
| SCHEMBL431370 | 0.83 | SCD (0.48) | SCDHCRTR1HCRTR2 | |
| SCHEMBL431368 | 0.83 | SCD (0.48) | SCDHCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8338607-B2 | Cyclic amine compounds and agents for pest control | NIPPON SODA CO., LTD. (JP) | 2012-12-25 | — | — | US | disclosed |
| EP-1947098-B1 | CYCLIC AMINE COMPOUNDS AND PEST CONTROL AGENT | NIPPON SODA CO (JP) | 2011-11-30 | — | — | EP | disclosed |
| US-20090259046-A1 | Cyclic Amine Compounds and Agents for Pest Control | NIPPON SODA CO., LTD. (JP) | 2009-10-15 | — | — | US | disclosed |
| EP-1947098-A1 | CYCLIC AMINE COMPOUNDS AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2008-07-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090259046-A1 | Cyclic Amine Compounds and Agents for Pest Control | NPR1, CYCS, CYC1 | SCD 4189/4885LIPC 3593/4885LIPG 4762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.